Episodes

Your Portfolio's Best Defense for an Uncertain 2023

Episode #298 | February 21, 2023

Episode #298 | February 21, 2023

Your Portfolio's Best Defense for an Uncertain 2023

In This Episode

When it comes to uncovering opportunities in an innovative sector, no one does it better than today's Stansberry Investor Hour guest. Dan hails him as "one of the most well-informed investors that I've ever met in my life"...

Stansberry Venture Technology editor Dave Lashmet returns to the show. He's our go-to for anything and everything related to emerging technologies. And his expertise in this field meshes perfectly with his venture-capitalist investing approach. (That's finding small, early-stage companies with the potential for massive breakout growth.) As such, his subscribers get a rare "industry insider" look into some of the most promising innovations in technology and medicine.

Whether it's the ongoing Russia-Ukraine war... more nuclear threats from North Korea... or the Chinese spy balloon fiasco... geopolitics has already become 2023's overarching theme. It's also why Dave is bullish on one corner of the market in particular...

The simple thesis is that we don't know what 2023 will be like for investors – if it'll be a bear, a bull, or a sideways market. But what we do know is that the best way to play defense in 2023 is going to be to buy defense stocks.

Both Investor Hour co-hosts agree, with Corey adding, "If inflation goes up because of these conflicts, whatever they may be, this is a way to protect your portfolio against that. At least have some exposure to defense stocks."

Dave also shares one company's stock that is poised to soar thanks to its groundbreaking new stealth technology. And just like other defense stocks on Dave's radar, it has a "very, very, very long [tail]" and "monopolies [on technologies]." Plus, Dave also details exactly what he looks for when screening military tech stocks, along with his "secret decoder ring" for choosing pharmaceutical companies to invest in.